A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 8, 2013, Pages 1936-1946

  Lagrange, Brice ^a,d   Martin, Romain Z ^a   Droin, Nathalie ^b   Aucagne, Romain ^a,e   Paggetti, Jérôme ^a,f   Largeot, Anne ^a   Itzykson, Raphaël ^b   Solary, Eric ^b   Delva, Laurent ^a   Bastie, Jean Noël ^a,c  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c HÔPITAL DU BOCAGE   (France)

^d UNIVERSITÉ LYON 1   (France)

^e INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^f CRP Santé Laboratoire d'Hémato Cancérologie Expérimentale   (Luxembourg)

Author keywords

Chronic myelomonocytic leukemia; Egr2; MiR 142 3p; Molecular circuitry; Monocyte macrophage differentiation

Indexed keywords

CD16 ANTIGEN; CD163 ANTIGEN; COLONY STIMULATING FACTOR 1; EARLY GROWTH RESPONSE FACTOR 2; MICRORNA; MICRORNA 142 3P; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR INDUCED GENE A; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MICROARRAY ANALYSIS; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; EARLY GROWTH RESPONSE PROTEIN 1; EARLY GROWTH RESPONSE PROTEIN 2; GPI-LINKED PROTEINS; HUMANS; K562 CELLS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICRORNAS; MONOCYTES; RECEPTORS, CELL SURFACE; RECEPTORS, IGG; REPRESSOR PROTEINS; UP-REGULATION;

EID: 84877820051     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.04.007     Document Type: Article

References (41)

1. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
2. Heisterkamp N., Groffen J., Stephenson J.R. Isolation of v-fms and its human cellular homolog. Virology 1983, 126:248-258.
3. Jacquel A., Benikhlef N., Paggetti J., Lalaoui N., Guery L., Dufour E.K., Ciudad M., Racoeur C., Micheau O., Delva L., Droin N., Solary E. Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages. Blood 2009, 114:3633-3641.
4. Xiong Y., Song D., Cai Y., Yu W., Yeung Y.G., Stanley E.R. A CSF-1 receptor phosphotyrosine 559 signaling pathway regulates receptor ubiquitination and tyrosine phosphorylation. J. Biol. Chem. 2011, 286:952-960.
5. Gobert Gosse S., Bourgin C., Liu W.Q., Garbay C., Mouchiroud G. M-CSF stimulated differentiation requires persistent MEK activity and MAPK phosphorylation independent of Grb2-Sos association and phosphatidylinositol 3-kinase activity. Cell. Signal. 2005, 17:1352-1362.
6. Rebe C., Cathelin S., Launay S., Filomenko R., Prevotat L., L'Ollivier C., Gyan E., Micheau O., Grant S., Dubart-Kupperschmitt A., Fontenay M., Solary E. Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood 2007, 109:1442-1450.
7. Friedman A.D. Transcriptional control of granulocyte and monocyte development. Oncogene 2007, 26:6816-6828.
8. Aziz A., Soucie E., Sarrazin S., Sieweke M.H. MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. Science 2009, 326:867-871.
9. Laslo P., Spooner C.J., Warmflash A., Lancki D.W., Lee H.J., Sciammas R., Gantner B.N., Dinner A.R., Singh H. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 2006, 126:755-766.
10. Krysinska H., Hoogenkamp M., Ingram R., Wilson N., Tagoh H., Laslo P., Singh H., Bonifer C. A two-step, PU.1-dependent mechanism for developmentally regulated chromatin remodeling and transcription of the c-fms gene. Mol. Cell. Biol. 2007, 27:878-887.
11. Kharbanda S., Nakamura T., Stone R., Hass R., Bernstein S., Datta R., Sukhatme V.P., Kufe D. Expression of the early growth response 1 and 2 zinc finger genes during induction of monocytic differentiation. J. Clin. Invest. 1991, 88:571-577.
12. Li T., Morgan M.J., Choksi S., Zhang Y., Kim Y.S., Liu Z.G. MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat. Immunol. 2010, 11:799-805.
13. O'Connell R.M., Rao D.S., Chaudhuri A.A., Boldin M.P., Taganov K.D., Nicoll J., Paquette R.L., Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 2008, 205:585-594.
14. Fontana L., Pelosi E., Greco P., Racanicchi S., Testa U., Liuzzi F., Croce C.M., Brunetti E., Grignani F., Peschle C. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat. Cell Biol. 2007, 9:775-787.
15. Droin N., Jacquel A., Hendra J.B., Racoeur C., Truntzer C., Pecqueur D., Benikhlef N., Ciudad M., Guery L., Jooste V., Dufour E., Fenaux P., Quesnel B., Kosmider O., Fontenay M., Ducoroy P., Solary E. Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia. Blood 2010, 115:78-88.
16. Sun W., Shen W., Yang S., Hu F., Li H., Zhu T.H. miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-beta. Cell Res. 2010, 20:1158-1169.
17. Svaren J., Sevetson B.R., Apel E.D., Zimonjic D.B., Popescu N.C., Milbrandt J. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol. 1996, 16:3545-3553.
18. Kumbrink J., Kirsch K.H., Johnson J.P. EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin. J. Cell. Biochem. 2010, 111:207-217.
19. Bastie J.N., Aucagne R., Droin N., Solary E., Delva L. Heterogeneity of molecular markers in chronic myelomonocytic leukemia: a disease associated with several gene alterations. Cell. Mol. Life Sci. 2012, 69:2853-2861.
20. Yoshida K., Sanada M., Shiraishi Y., Nowak D., Nagata Y., Yamamoto R., Sato Y., Sato-Otsubo A., Kon A., Nagasaki M., Chalkidis G., Suzuki Y., Shiosaka M., Kawahata R., Yamaguchi T., Otsu M., Obara N., Sakata-Yanagimoto M., Ishiyama K., Mori H., Nolte F., Hofmann W.K., Miyawaki S., Sugano S., Haferlach C., Koeffler H.P., Shih L.Y., Haferlach T., Chiba S., Nakauchi H., Miyano S., Ogawa S. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011, 478:64-69.
21. Parikh S.A., Tefferi A. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management. Am. J. Hematol. 2012, 87:610-619.
22. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foa R., Schliwka J., Fuchs U., Novosel A., Muller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
23. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
24. Merkerova M., Belickova M., Bruchova H. Differential expression of microRNAs in hematopoietic cell lineages. Eur. J. Haematol. 2008, 81:304-310.
25. Bissels U., Wild S., Tomiuk S., Hafner M., Scheel H., Mihailovic A., Choi Y.H., Tuschl T., Bosio A. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells. Stem Cells 2011, 29:847-857.
26. Nishiyama T., Kaneda R., Ono T., Tohyama S., Hashimoto H., Endo J., Tsuruta H., Yuasa S., Ieda M., Makino S., Fukuda K. miR-142-3p is essential for hematopoiesis and affects cardiac cell fate in zebrafish. Biochem. Biophys. Res. Commun. 2012, 425:755-761.
27. Huang B., Zhao J., Lei Z., Shen S., Li D., Shen G.X., Zhang G.M., Feng Z.H. miR-142-3p restricts cAMP production in CD4+ CD25- T cells and CD4+ CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep. 2009, 10:180-185.
28. Risoe P.K., Ryg U., Wang Y.Y., Rutkovskiy A., Smedsrod B., Valen G., Dahle M.K. Cecal ligation and puncture sepsis is associated with attenuated expression of adenylyl cyclase 9 and increased miR142-3p. Shock 2011, 36:390-395.
29. Sun Y., Varambally S., Maher C.A., Cao Q., Chockley P., Toubai T., Malter C., Nieves E., Tawara I., Wang Y., Ward P.A., Chinnaiyan A., Reddy P. Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality. Blood 2011, 117:6172-6183.
30. Riester A., Issler O., Spyroglou A., Rodrig S.H., Chen A., Beuschlein F. ACTH-dependent regulation of microRNA as endogenous modulators of glucocorticoid receptor expression in the adrenal gland. Endocrinology 2012, 153:212-222.
31. Wu L., Cai C., Wang X., Liu M., Li X., Tang H. MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett. 2011, 585:1322-1330.
32. Zhao J., Cao Y., Lei Z., Yang Z., Zhang B., Huang B. Selective depletion of CD4+ CD25+ Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels. Cancer Res. 2010, 70:4850-4858.
33. Brown B.D., Venneri M.A., Zingale A., Sergi Sergi L., Naldini L. Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat. Med. 2006, 12:585-591.
34. Gomez-Martin D., Diaz-Zamudio M., Galindo-Campos M., Alcocer-Varela J. Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity. Autoimmun. Rev. 2010, 9:454-458.
35. Pospisil V., Vargova K., Kokavec J., Rybarova J., Savvulidi F., Jonasova A., Necas E., Zavadil J., Laslo P., Stopka T. Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation. EMBO J. 2011, 30:4450-4464.
36. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., Bozzoni I. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005, 123:819-831.
37. Flamant S., Ritchie W., Guilhot J., Holst J., Bonnet M.L., Chomel J.C., Guilhot F., Turhan A.G., Rasko J.E. Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica 2010, 95:1325-1333.
38. Ju X., Li D., Shi Q., Hou H., Sun N., Shen B. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia. Pediatr. Hematol. Oncol. 2009, 26:1-10.
39. Lv M., Zhang X., Jia H., Li D., Zhang B., Zhang H., Hong M., Jiang T., Jiang Q., Lu J., Huang X., Huang B. An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-alpha and cAMP/PKA pathways. Leukemia 2012, 26:769-777.
40. Zhao J.J., Lin J., Lwin T., Yang H., Guo J., Kong W., Dessureault S., Moscinski L.C., Rezania D., Dalton W.S., Sotomayor E., Tao J., Cheng J.Q. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010, 115:2630-2639.
41. Wang X.S., Gong J.N., Yu J., Wang F., Zhang X.H., Yin X.L., Tan Z.Q., Luo Z.M., Yang G.H., Shen C., Zhang J.W. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood 2012.